COVID-19 Q&A for Patients
Corona and COVID-19 can lead to many questions. We want to answer a few of them, provide some general information and give some recommendations.
Search
The Core of our Leitbild
Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.
Our Health and Safety initiative - BE SAFE
We strive to keep our employees in good health, supporting their well-being across all working environments. Learn about our BE SAFE initiative.
COVID-19 Q&A for people with diabetes
Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
COVID-19 Supply Chain and Production
Supplying patients and customers with their medicines is our highest priority. Learn about COVID-19's impact on our supply chain and production here.
Our Approach
As a family-owned company, we are driven by the ambition to serve humankind by improving human and animal health. Find out more about our approach here.
The Supplier Code of Conduct
Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
Introducing Karl and Klara Kidney
Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways. Click here to find out more.
Trust Through Transparency
Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
Bringing Precision to Psychiatry
Dr Hugh Marston and Dr Vikas Mohan Sharma discuss how precision psychiatry can enable people living with mental health conditions to thrive. Learn more.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Innovation Needs Transparency
At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
COVID-19 Mexico - The value of teamwork
During the pandemic, Fabiola Villegas, contributed with creativity and ingenuity from her region in Uruapan, Michoacán, Mexico. Click here to learn more.
How pets made the pandemic bearable?
Lockdown wasn’t easy but having us work from home was certainly delightful for our pets. Learn some insights from the APPA COVID-19 Pulse Study.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Boosting performance with an inclusive performance culture
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
COVID-19 Volunteering in India
Learn about our employees in India volunteering during COVID-19, including Rashmi Suvarna, Head of Procurement at Boehringer Ingelheim India.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Say no to the uninvited guests
Boehringer Ingelheim aims to raise awareness of the issues & risks that parasites can have on cats. Click here to find out more information.
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.